192 related articles for article (PubMed ID: 27023676)
41. The role of phenoconversion in the pharmacogenetics of psychiatric medication.
Hahn M; Roll SC
Pharmacogenomics; 2023 Jun; 24(9):485-487. PubMed ID: 37427432
[No Abstract] [Full Text] [Related]
42. A taste of individualized medicine: physicians' reactions to automated genetic interpretations.
Lærum H; Bremer S; Bergan S; Grünfeld T
J Am Med Inform Assoc; 2014 Feb; 21(e1):e143-6. PubMed ID: 24001515
[TBL] [Abstract][Full Text] [Related]
43. Pharmacogenetics--genomics and personalized psychiatry.
Möller HJ; Rujescu D
Eur Psychiatry; 2010 Jun; 25(5):291-3. PubMed ID: 20392609
[TBL] [Abstract][Full Text] [Related]
44. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
45. Clinical implementation of pharmacogenetics.
García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
[TBL] [Abstract][Full Text] [Related]
46. Systems-guided support to enable personalized medicine.
White L; Rule D
MLO Med Lab Obs; 2015 Nov; 47(11):40. PubMed ID: 26685429
[No Abstract] [Full Text] [Related]
47. Integrated precision medicine: the role of electronic health records in delivering personalized treatment.
Sitapati A; Kim H; Berkovich B; Marmor R; Singh S; El-Kareh R; Clay B; Ohno-Machado L
Wiley Interdiscip Rev Syst Biol Med; 2017 May; 9(3):. PubMed ID: 28207198
[TBL] [Abstract][Full Text] [Related]
48. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
[TBL] [Abstract][Full Text] [Related]
49. PharmCAT: A Pharmacogenomics Clinical Annotation Tool.
Klein TE; Ritchie MD
Clin Pharmacol Ther; 2018 Jul; 104(1):19-22. PubMed ID: 29194583
[TBL] [Abstract][Full Text] [Related]
50. Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.
Kapoor R; Tan-Koi WC; Teo YY
Eur J Hum Genet; 2016 Dec; 24(12):1651-1657. PubMed ID: 27577547
[TBL] [Abstract][Full Text] [Related]
51. Should we be 'pushing meds'? The implications of pharmacogenomics.
Bray J; Clarke C; Brennan G; Muncey T
J Psychiatr Ment Health Nurs; 2008 Jun; 15(5):357-64. PubMed ID: 18454820
[TBL] [Abstract][Full Text] [Related]
52. Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine.
Crettol S; de Leon J; Hiemke C; Eap CB
Clin Pharmacol Ther; 2014 Mar; 95(3):254-7. PubMed ID: 24196844
[No Abstract] [Full Text] [Related]
53. [Personalised medicine applied to mental health: Precision psychiatry].
Vieta E
Rev Psiquiatr Salud Ment; 2015; 8(3):117-8. PubMed ID: 25959401
[No Abstract] [Full Text] [Related]
54. Improving health care outcomes through personalized comparisons of treatment effectiveness based on electronic health records.
Hoffman S; Podgurski A
J Law Med Ethics; 2011; 39(3):425-36. PubMed ID: 21871040
[TBL] [Abstract][Full Text] [Related]
55. Personalised Medicine Possible With Real-Time Integration of Genomic and Clinical Data To Inform Clinical Decision-Making.
Martin-Sanchez F; Turner M; Johnstone A; Heffer L; Rafael N; ; Bakker T; Thorne N; Macciocca I; Gaff C
Stud Health Technol Inform; 2015; 216():1052. PubMed ID: 26262351
[TBL] [Abstract][Full Text] [Related]
56. Role of genomics on the path to personalized medicine.
Tremblay J; Hamet P
Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
[TBL] [Abstract][Full Text] [Related]
57. Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.
Harada S; Zhou Y; Duncan S; Armstead AR; Coshatt GM; Dillon C; Brott BC; Willig J; Alsip JA; Hillegass WB; Limdi NA
Clin Pharmacol Ther; 2017 Sep; 102(3):493-501. PubMed ID: 28124392
[TBL] [Abstract][Full Text] [Related]
58. Pharmacogenetics, race, and psychiatry: prospects and challenges.
Jones DS; Perlis RH
Harv Rev Psychiatry; 2006; 14(2):92-108. PubMed ID: 16603475
[TBL] [Abstract][Full Text] [Related]
59. [Personalized medicine for epilepsy based on the pharmacogenomic testing].
Yoshida S; Sugawara T; Nishio T; Kaneko S
Brain Nerve; 2011 Apr; 63(4):295-9. PubMed ID: 21441631
[TBL] [Abstract][Full Text] [Related]
60. Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.
Vo TT; Bell GC; Owusu Obeng A; Hicks JK; Dunnenberger HM
Pharmacotherapy; 2017 Sep; 37(9):1014-1022. PubMed ID: 28699700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
